These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 25559545)

  • 21. [The significance of early diagnosis of cancer-related hypercalcaemia].
    Radványi I; Csikós A; Balogh S
    Orv Hetil; 2013 Sep; 154(35):1367-73. PubMed ID: 23974972
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Transient improvement of severe pain from fibrous dysplasia of bone with denosumab treatment.
    Benhamou J; Gensburger D; Chapurlat R
    Joint Bone Spine; 2014 Dec; 81(6):549-50. PubMed ID: 24962974
    [No Abstract]   [Full Text] [Related]  

  • 23. [Denosumab--treatment of osteoporosis and cancer].
    Vestergaard P
    Ugeskr Laeger; 2012 Mar; 174(12):781. PubMed ID: 22433538
    [No Abstract]   [Full Text] [Related]  

  • 24. Protracted hypocalcaemia following a single dose of denosumab in humoral hypercalcaemia of malignancy due to PTHrP-secreting neuroendocrine tumour.
    Teng J; Abell S; Hicks RJ; Hofman MS; Sachithanandan N; McKelvie P; MacIsaac RJ
    Clin Endocrinol (Oxf); 2014 Dec; 81(6):940-2. PubMed ID: 24890549
    [No Abstract]   [Full Text] [Related]  

  • 25. Aneurysmal bone cysts: denosumab extends its reach.
    Purdue E
    Transl Res; 2014 Aug; 164(2):135-8. PubMed ID: 24837849
    [No Abstract]   [Full Text] [Related]  

  • 26. Severe hypocalcemia following denosumab injection in a hemodialysis patient.
    McCormick BB; Davis J; Burns KD
    Am J Kidney Dis; 2012 Oct; 60(4):626-8. PubMed ID: 22854051
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Bone-related complications and quality of life in advanced breast cancer: results from a randomized phase III trial of denosumab versus zoledronic acid.
    Martin M; Bell R; Bourgeois H; Brufsky A; Diel I; Eniu A; Fallowfield L; Fujiwara Y; Jassem J; Paterson AH; Ritchie D; Steger GG; Stopeck A; Vogel C; Fan M; Jiang Q; Chung K; Dansey R; Braun A
    Clin Cancer Res; 2012 Sep; 18(17):4841-9. PubMed ID: 22893628
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Denosumab: an antifracture therapy for postmenopausal women with osteoporosis.
    Jiang X; Schnatz PF
    Menopause; 2013 Feb; 20(2):117-9. PubMed ID: 23299707
    [No Abstract]   [Full Text] [Related]  

  • 29. Denosumab for the treatment of osteoporosis and cancer-related conditions.
    Lewiecki EM; Bilezikian JP
    Clin Pharmacol Ther; 2012 Jan; 91(1):123-33. PubMed ID: 22158568
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Neoadjuvant denosumab for extensive giant cell tumor in os ischium: a case report.
    van der Heijden L; van de Sande MA; Hogendoorn PC; Gelderblom H; Dijkstra PD
    Acta Orthop; 2015 Jun; 86(3):393-5. PubMed ID: 25684041
    [No Abstract]   [Full Text] [Related]  

  • 31. Denosumab: Excellent response of metastatic giant cell tumor of the bone.
    Ulas A; Bulent Akinci M; Silay K; Sendur MA; Sener Dede D; Yalcin B
    J BUON; 2015; 20(2):666-7. PubMed ID: 26011370
    [No Abstract]   [Full Text] [Related]  

  • 32. Response.
    Glezerman IG; Hu MI; Jain RK
    J Natl Cancer Inst; 2014 Jul; 106(7):. PubMed ID: 24906399
    [No Abstract]   [Full Text] [Related]  

  • 33. [Hypercalcemia in myeloma].
    Abe M
    Nihon Rinsho; 2007 Dec; 65(12):2245-9. PubMed ID: 18069268
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Calcitriol: a better option than vitamin D in denosumab-treated patients with kidney failure?
    Buonerba C; Caraglia M; Malgieri S; Perri F; Bosso D; Federico P; Ferro M; Rizzo M; Palmieri G; Di Lorenzo G
    Expert Opin Biol Ther; 2013 Feb; 13(2):149-51. PubMed ID: 23265605
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Osteonecrosis of jaw with the use of denosumab.
    Akhtar NH; Afzal MZ; Ahmed AA
    J Cancer Res Ther; 2011; 7(4):499-500. PubMed ID: 22269422
    [No Abstract]   [Full Text] [Related]  

  • 36. Re: Denosumab and bone metastasis-free survival in men with nonmetastatic castration-resistant prostate cancer: exploratory analyses by baseline prostate-specific antigen doubling time.
    Taneja SS
    J Urol; 2014 Aug; 192(2):421-2. PubMed ID: 25034990
    [No Abstract]   [Full Text] [Related]  

  • 37. Denosumab: a breakthrough in treatment of giant-cell tumour of bone?
    Balke M; Hardes J
    Lancet Oncol; 2010 Mar; 11(3):218-9. PubMed ID: 20149737
    [No Abstract]   [Full Text] [Related]  

  • 38. Denosumab, osteoporosis, and prevention of fractures.
    Kiechl S; Willeit J; Schett G
    N Engl J Med; 2009 Nov; 361(22):2188-9; author reply 2190-1. PubMed ID: 19940304
    [No Abstract]   [Full Text] [Related]  

  • 39. [Denosumab finds its way into the updated DVO guidelines].
    Fessler B
    Med Monatsschr Pharm; 2015 Apr; 38(4):147-8. PubMed ID: 26364385
    [No Abstract]   [Full Text] [Related]  

  • 40. [Denosumab. The first inhibitor of RANK-ligand for treatment of osteoporosis].
    Bruhn C
    Med Monatsschr Pharm; 2010 Oct; 33(10):370-5. PubMed ID: 21072910
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.